Etoricoxib and the treatment of ankylosing spondylitis

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.8, Iss.12, 2012-12, pp. : 1599-1608

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Etoricoxib cost effective for ankylosing spondylitis in the UK

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 600, 2010-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis

By Jansen Jeroen P.

PharmacoEconomics, Vol. 28, Iss. 4, 2010-04 ,pp. : 323-344

Adis International

Access to resources Recommend Favorite

Etoricoxib: A Review of its Use in the Symptomatic Treatment of Osteoarthritis, Rheumatoid Arthritis, Ankylosing Spondylitis and Acute Gouty Arthritis

By Croom Katherine F. Siddiqui M. Asif A.

Drugs, Vol. 69, Iss. 11, 2009-07 ,pp. : 1513-1532

Adis International

Access to resources Recommend Favorite

Adalimumab for the treatment of ankylosing spondylitis

By Sieper Joachim Rudwaleit Martin Braun Jürgen

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 6, 2007-04 ,pp. : 831-838

Informa Healthcare

Access to resources Recommend Favorite

Recent progress in ankylosing spondylitis treatment

By Toussirot Éric Wendling Daniel

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 1, 2003-01 ,pp. : 1-12

Informa Healthcare

Access to resources Recommend Favorite